ACAD vs WST · P/E 15, rev $576.0M vs P/E 35, rev $1.72B
ACADIA Pharmaceuticals Inc (ACAD) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the ACAD and WST stock pages for the full models.
Not investment advice.